SCHEMBL18504070

SCHEMBL18504070

c1cc(-c2cccc(-c3nc(-c4cccc(-c5cccc6ccccc56)c4)c4ccccc4n3)c2)cc(-c2ccc3c4ccccc4c4ccccc4c3c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ ATM Q13315 2/20 0.48
▸ ADORA2A P29274 4/20 0.39
▸ WHR1 P49842 1/20 0.39
▸ MCL1 Q07820 1/20 0.39
▸ ACMSD Q8TDX5 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.39
▸ MAPT P10636 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18504072 0.95 MEN1 (0.51) MEN1KMT2AATMADORA2AWHR1
SCHEMBL18504123 0.95 ATM (0.51) MEN1KMT2AATMADORA2AWHR1
SCHEMBL18503957 0.92 MEN1 (0.49) MEN1KMT2AATMADORA2AWHR1
SCHEMBL18504018 0.91 MEN1 (0.48) MEN1KMT2AATMADORA2AWHR1
SCHEMBL18504112 0.89 MEN1 (0.55) MEN1KMT2AATMADORA2AWHR1
SCHEMBL18504071 0.89 MEN1 (0.55) MEN1KMT2AATMADORA2AWHR1
SCHEMBL18503977 0.88 MEN1 (0.55) MEN1KMT2AATMADORA2AWHR1
SCHEMBL18504108 0.88 ATM (0.55) MEN1KMT2AATMADORA2AWHR1
SCHEMBL18504109 0.88 MEN1 (0.60) MEN1KMT2AATMADORA2AWHR1
SCHEMBL17227662 0.88 MEN1 (0.60) MEN1KMT2AATMADORA2AWHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device SAMSUNG SDI CO., LTD. (KR) 2019-10-15 — — US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 — — US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device OXER1, OCIAD1, OCIAD2 MEN1 1724/4885KMT2A 4198/4885ATM 4155/4885
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE OXER1, OCIAD1, OCIAD2 MEN1 1724/4885KMT2A 4198/4885ATM 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback